Abiraterone
The serum concentration of Propafenone can be increased when it is combined with Abiraterone.
Acebutolol
The serum concentration of Acebutolol can be increased when it is combined with Propafenone.
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Propafenone.
Advertisement
Acemetacin
Acemetacin may decrease the antihypertensive activities of Propafenone.
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.
Acepromazine
Propafenone may increase the orthostatic hypotensive activities of Acepromazine.
Advertisement
Aceprometazine
Aceprometazine may increase the hypotensive activities of Propafenone.
Acetohexamide
Propafenone may increase the hypoglycemic activities of Acetohexamide.
Acetyl salicylate
Acetylsalicylic acid may decrease the antihypertensive activities of Propafenone.
Advertisement
Acetyl Sulfisoxazole
The serum concentration of Propafenone can be increased when it is combined with Acetyl sulfisoxazole.
Acetylcholine
The risk or severity of adverse effects can be increased when Propafenone is combined with Acetylcholine.
Acetylcholine Chloride
The risk or severity of adverse effects can be increased when Propafenone is combined with Acetylcholine.
Acetyldigitoxin
The serum concentration of Acetyldigitoxin can be increased when it is combined with Propafenone.
Adapalene
Adapalene may decrease the antihypertensive activities of Propafenone.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Propafenone.
Ajmaline
Propafenone may increase the arrhythmogenic activities of Ajmaline.
Albuterol
Salbutamol may increase the QTc-prolonging activities of Propafenone.
Alfentanil
Alfentanil may increase the bradycardic activities of Propafenone.
Alfuzosin
Propafenone may increase the orthostatic hypotensive activities of Alfuzosin.
Alminoprofen
Alminoprofen may decrease the antihypertensive activities of Propafenone.
Alprenolol
The serum concentration of Alprenolol can be increased when it is combined with Propafenone.
Amantadine
Amantadine may increase the QTc-prolonging activities of Propafenone.
Ambenonium
Ambenonium may increase the bradycardic activities of Propafenone.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Propafenone.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Propafenone.
Aminophylline
The serum concentration of Aminophylline can be increased when it is combined with Propafenone.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Propafenone.
Amitriptyline
Propafenone may increase the orthostatic hypotensive activities of Amitriptyline.
Amobarbital
The serum concentration of Propafenone can be decreased when it is combined with Amobarbital.
Amodiaquine
The serum concentration of Amodiaquine can be increased when it is combined with Propafenone.
Amoxapine
Propafenone may increase the orthostatic hypotensive activities of Amoxapine.
Anagrelide
Propafenone may increase the QTc-prolonging activities of Anagrelide.
Antipyrine
Antipyrine may decrease the antihypertensive activities of Propafenone.
Apalutamide
The serum concentration of Propafenone can be decreased when it is combined with Apalutamide.
Apazone
Azapropazone may decrease the antihypertensive activities of Propafenone.
Apomorphine
Apomorphine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Apremilast
Apremilast may decrease the antihypertensive activities of Propafenone.
Aprepitant
The serum concentration of Propafenone can be increased when it is combined with Aprepitant.
Arformoterol
Arformoterol may increase the QTc-prolonging activities of Propafenone.
Aripiprazole
Propafenone may increase the orthostatic hypotensive activities of Aripiprazole.
Arsenic Trioxide
Propafenone may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
The serum concentration of Artemether can be increased when it is combined with Propafenone.
Asenapine
The serum concentration of Asenapine can be increased when it is combined with Propafenone.
Aspirin
Acetylsalicylic acid may decrease the antihypertensive activities of Propafenone.
Atazanavir
The serum concentration of Propafenone can be increased when it is combined with Atazanavir.
Atenolol
The serum concentration of Atenolol can be increased when it is combined with Propafenone.
Atomoxetine
The serum concentration of Atomoxetine can be increased when it is combined with Propafenone.
Azelastine
Azelastine may decrease the antihypertensive activities of Propafenone.
Azithromycin
Azithromycin may increase the QTc-prolonging activities of Propafenone.
Balsalazide
Balsalazide may decrease the antihypertensive activities of Propafenone.
Barbexaclone
The serum concentration of Propafenone can be decreased when it is combined with Barbexaclone.
Barbital
The serum concentration of Propafenone can be decreased when it is combined with Barbital.
Bedaquiline
Propafenone may increase the QTc-prolonging activities of Bedaquiline.
Bendroflumethiazide
Bendroflumethiazide may increase the bradycardic activities of Propafenone.
Benzphetamine
Benzphetamine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Benzydamine
Benzydamine may decrease the antihypertensive activities of Propafenone.
Beractant
Propafenone may increase the bradycardic activities of Beractant.
Betaxolol
The serum concentration of Betaxolol can be increased when it is combined with Propafenone.
Bethanechol
The risk or severity of adverse effects can be increased when Propafenone is combined with Bethanechol.
Bethanidine
Bethanidine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Bisoprolol
The serum concentration of Bisoprolol can be increased when it is combined with Propafenone.
Boceprevir
The serum concentration of Propafenone can be increased when it is combined with Boceprevir.
Bopindolol
The serum concentration of Bopindolol can be increased when it is combined with Propafenone.
Bortezomib
The serum concentration of Propafenone can be increased when it is combined with Bortezomib.
Bosentan
The serum concentration of Propafenone can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Propafenone can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Propafenone.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Propafenone.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Propafenone.
Bretylium
Bretylium may increase the bradycardic activities of Propafenone.
Brexpiprazole
Propafenone may increase the orthostatic hypotensive activities of Brexpiprazole.
Brimonidine
Brimonidine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Bromfenac
Bromfenac may decrease the antihypertensive activities of Propafenone.
Bromocriptine
Bromocriptine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Bufexamac
Bufexamac may decrease the antihypertensive activities of Propafenone.
Bunazosin
Propafenone may increase the orthostatic hypotensive activities of Bunazosin.
Bupivacaine
The serum concentration of Bupivacaine can be increased when it is combined with Propafenone.
Bupranolol
The serum concentration of Bupranolol can be increased when it is combined with Propafenone.
Bupropion
The serum concentration of Propafenone can be increased when it is combined with Bupropion.
Buserelin
Buserelin may increase the QTc-prolonging activities of Propafenone.
Cabergoline
Propafenone may increase the vasoconstricting activities of Cabergoline.
Caffeine
The metabolism of Propafenone can be decreased when combined with Caffeine.
Calfactant
Propafenone may increase the bradycardic activities of Calfactant.
Carbachol
The risk or severity of adverse effects can be increased when Propafenone is combined with Carbachol.
Carbamazepine
The serum concentration of Propafenone can be decreased when it is combined with Carbamazepine.
Carprofen
Carprofen may decrease the antihypertensive activities of Propafenone.
Carteolol
The serum concentration of Carteolol can be increased when it is combined with Propafenone.
Carvedilol
The serum concentration of Carvedilol can be increased when it is combined with Propafenone.
Celecoxib
The serum concentration of Celecoxib can be increased when it is combined with Propafenone.
Celiprolol
The serum concentration of Celiprolol can be increased when it is combined with Propafenone.
Ceritinib
Propafenone may increase the bradycardic activities of Ceritinib.
Cevimeline
The risk or severity of adverse effects can be increased when Propafenone is combined with Cevimeline.
Chloroquine
The serum concentration of Chloroquine can be increased when it is combined with Propafenone.
Chlorpromazine
The serum concentration of Chlorpromazine can be increased when it is combined with Propafenone.
Chlorpropamide
Propafenone may increase the hypoglycemic activities of Chlorpropamide.
Cholecalciferol
The serum concentration of Cholecalciferol can be increased when it is combined with Propafenone.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may decrease the antihypertensive activities of Propafenone.
Cimetidine
The serum concentration of Propafenone can be increased when it is combined with Cimetidine.
Cinacalcet
The serum concentration of Propafenone can be increased when it is combined with Cinacalcet.
Ciprofloxacin
Ciprofloxacin may increase the QTc-prolonging activities of Propafenone.
Cisapride
Propafenone may increase the QTc-prolonging activities of Cisapride.
Citalopram
The serum concentration of Citalopram can be increased when it is combined with Propafenone.
Clarithromycin
The serum concentration of Propafenone can be increased when it is combined with Clarithromycin.
Clemastine
The serum concentration of Clemastine can be increased when it is combined with Propafenone.
Clobazam
The serum concentration of Clobazam can be increased when it is combined with Propafenone.
Clomipramine
The serum concentration of Clomipramine can be increased when it is combined with Propafenone.
Clonidine
Clonidine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Clonixin
Clonixin may decrease the antihypertensive activities of Propafenone.
Clotrimazole
The serum concentration of Clotrimazole can be increased when it is combined with Propafenone.
Clozapine
The serum concentration of Clozapine can be increased when it is combined with Propafenone.
Cobicistat
The serum concentration of Cobicistat can be increased when it is combined with Propafenone.
Cocaine
The serum concentration of Propafenone can be increased when it is combined with Cocaine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Propafenone.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Propafenone.
Crizotinib
The serum concentration of Propafenone can be increased when it is combined with Crizotinib.
Curcumin
The serum concentration of Curcumin can be increased when it is combined with Propafenone.
Cyclosporine
The serum concentration of Propafenone can be increased when it is combined with Cyclosporine.
Cyproterone Acetate
The serum concentration of Propafenone can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Propafenone.
Dabrafenib
The serum concentration of Propafenone can be decreased when it is combined with Dabrafenib.
Dapiprazole
Propafenone may increase the orthostatic hypotensive activities of Dapiprazole.
Darifenacin
The serum concentration of Darifenacin can be increased when it is combined with Propafenone.
Darunavir
The serum concentration of Propafenone can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Propafenone can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Propafenone can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Propafenone can be decreased when it is combined with Deferasirox.
Degarelix
Degarelix may increase the QTc-prolonging activities of Propafenone.
Delavirdine
The serum concentration of Propafenone can be increased when it is combined with Delavirdine.
Demecarium
Demecarium may increase the bradycardic activities of Propafenone.
Desflurane
Desflurane may increase the QTc-prolonging activities of Propafenone.
Desipramine
The serum concentration of Desipramine can be increased when it is combined with Propafenone.
Deslanoside
The serum concentration of Deslanoside can be increased when it is combined with Propafenone.
Desvenlafaxine
The serum concentration of Propafenone can be increased when it is combined with Desvenlafaxine.
Dexmedetomidine
Dexmedetomidine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Dextroamphetamine
Propafenone may increase the orthostatic hypotensive activities of Dextroamphetamine.
Diclofenac
Diclofenac may decrease the antihypertensive activities of Propafenone.
Dicumarol
The serum concentration of Dicoumarol can be increased when it is combined with Propafenone.
Diflunisal
Diflunisal may decrease the antihypertensive activities of Propafenone.
Digitoxin
The serum concentration of Digitoxin can be increased when it is combined with Propafenone.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Propafenone.
Dihydroergotamine
The serum concentration of Propafenone can be increased when it is combined with Dihydroergotamine.
Diltiazem
The serum concentration of Propafenone can be increased when it is combined with Diltiazem.
Diphenhydramine
The serum concentration of Diphenhydramine can be increased when it is combined with Propafenone.
Dipivefrin
Dipivefrin may increase the atrioventricular blocking (AV block) activities of Propafenone.
Dipyridamole
Dipyridamole may increase the bradycardic activities of Propafenone.
Dipyrone
Metamizole may decrease the antihypertensive activities of Propafenone.
Distigmine
Distigmine may increase the bradycardic activities of Propafenone.
Dofetilide
Propafenone may increase the arrhythmogenic activities of Dofetilide.
Dolasetron
Dolasetron may increase the QTc-prolonging activities of Propafenone.
Domperidone
Propafenone may increase the QTc-prolonging activities of Domperidone.
Donepezil
Donepezil may increase the bradycardic activities of Propafenone.
Dothiepin
The serum concentration of Propafenone can be increased when it is combined with Dosulepin.
Doxazosin
Propafenone may increase the orthostatic hypotensive activities of Doxazosin.
Doxepin
Propafenone may increase the orthostatic hypotensive activities of Doxepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Propafenone.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Propafenone.
Doxycycline
The serum concentration of Propafenone can be increased when it is combined with Doxycycline.
Doxycycline Anhydrous
The serum concentration of Propafenone can be increased when it is combined with Doxycycline.
Dronedarone
Propafenone may increase the arrhythmogenic activities of Dronedarone.
Droperidol
Droperidol may increase the QTc-prolonging activities of Propafenone.
Droxicam
Droxicam may decrease the antihypertensive activities of Propafenone.
Droxidopa
Droxidopa may increase the atrioventricular blocking (AV block) activities of Propafenone.
Duloxetine
The serum concentration of Duloxetine can be increased when it is combined with Propafenone.
Dyphylline
The serum concentration of Dyphylline can be increased when it is combined with Propafenone.
Echothiophate
Echothiophate may increase the bradycardic activities of Propafenone.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Propafenone.
Edrophonium
Edrophonium may increase the bradycardic activities of Propafenone.
Eliglustat
The serum concentration of Eliglustat can be increased when it is combined with Propafenone.
Enzalutamide
The serum concentration of Propafenone can be decreased when it is combined with Enzalutamide.
Epinephrine
Epinephrine may increase the atrioventricular blocking (AV block) activities of Propafenone.
ergoloid mesylates, USP
Propafenone may increase the vasoconstricting activities of Ergoloid mesylate.
Ergonovine
Propafenone may increase the vasoconstricting activities of Ergonovine.
Ergotamine
Ergotamine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Eribulin
Eribulin may increase the QTc-prolonging activities of Propafenone.
Erythromycin
The serum concentration of Propafenone can be increased when it is combined with Erythromycin.
Escitalopram
Propafenone may increase the QTc-prolonging activities of Escitalopram.
Esmolol
The serum concentration of Esmolol can be increased when it is combined with Propafenone.
Etanercept
Etanercept may decrease the antihypertensive activities of Propafenone.
Etodolac
Etodolac may decrease the antihypertensive activities of Propafenone.
Etofenamate
Etofenamate may decrease the antihypertensive activities of Propafenone.
Etomidate
Etomidate may increase the atrioventricular blocking (AV block) activities of Propafenone.
Etoricoxib
Etoricoxib may decrease the antihypertensive activities of Propafenone.
Etravirine
The serum concentration of Propafenone can be decreased when it is combined with Etravirine.
Evening primrose oil
Evening primrose oil may decrease the antihypertensive activities of Propafenone.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Propafenone.
Ezogabine
Ezogabine may increase the QTc-prolonging activities of Propafenone.
Famotidine
Famotidine may increase the QTc-prolonging activities of Propafenone.
Felbamate
Felbamate may increase the QTc-prolonging activities of Propafenone.
Felbinac
Felbinac may decrease the antihypertensive activities of Propafenone.
Fenbufen
Fenbufen may decrease the antihypertensive activities of Propafenone.
Fenoprofen
Fenoprofen may decrease the antihypertensive activities of Propafenone.
Fentanyl
Fentanyl may increase the bradycardic activities of Propafenone.
Ferulic Acid
Ferulic acid may decrease the antihypertensive activities of Propafenone.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Propafenone.
Fingolimod
Propafenone may increase the bradycardic activities of Fingolimod.
Flecainide
Propafenone may increase the QTc-prolonging activities of Flecainide.
Floctafenine
The risk or severity of adverse effects can be increased when Propafenone is combined with Floctafenine.
Fluconazole
The serum concentration of Propafenone can be increased when it is combined with Fluconazole.
Fluindione
The serum concentration of Fluindione can be increased when it is combined with Propafenone.
Fluoxetine
Propafenone may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Propafenone may increase the QTc-prolonging activities of Flupentixol.
Fluphenazine
Fluphenazine may increase the hypotensive activities of Propafenone.
Flurbiprofen
Flurbiprofen may decrease the antihypertensive activities of Propafenone.
Fluvoxamine
The serum concentration of Propafenone can be increased when it is combined with Fluvoxamine.
Formoterol
Formoterol may increase the QTc-prolonging activities of Propafenone.
Fosamprenavir
The serum concentration of Propafenone can be increased when it is combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Propafenone can be increased when it is combined with Fosaprepitant.
Foscarnet
Foscarnet may increase the QTc-prolonging activities of Propafenone.
Fosphenytoin
The serum concentration of Propafenone can be decreased when it is combined with Fosphenytoin.
Fusidate
The serum concentration of Propafenone can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Propafenone can be increased when it is combined with Fusidic Acid.
Gadobenate
Gadobenic acid may increase the QTc-prolonging activities of Propafenone.
Galantamine
Galantamine may increase the QTc-prolonging activities of Propafenone.
Gallamine Triethiodide
Gallamine Triethiodide may increase the bradycardic activities of Propafenone.
Gemifloxacin
Gemifloxacin may increase the QTc-prolonging activities of Propafenone.
Gemifloxacin Mesylate
Gemifloxacin may increase the QTc-prolonging activities of Propafenone.
Ginkgo biloba extract
Ginkgo biloba may increase the bradycardic activities of Propafenone.
Glibornuride
Propafenone may increase the hypoglycemic activities of Glibornuride.
Gliclazide
Propafenone may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Propafenone may increase the hypoglycemic activities of Glimepiride.
Glipizide
Propafenone may increase the hypoglycemic activities of Glipizide.
Gliquidone
Propafenone may increase the hypoglycemic activities of Gliquidone.
Glyburide
Propafenone may increase the hypoglycemic activities of Glyburide.
Goserelin
Goserelin may increase the QTc-prolonging activities of Propafenone.
Granisetron
Granisetron may increase the QTc-prolonging activities of Propafenone.
Guanabenz
Guanabenz may increase the atrioventricular blocking (AV block) activities of Propafenone.
Guanfacine
Guanfacine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Haloperidol
The serum concentration of Haloperidol can be increased when it is combined with Propafenone.
Hexobarbital
The serum concentration of Propafenone can be decreased when it is combined with Hexobarbital.
Histrelin
Histrelin may increase the QTc-prolonging activities of Propafenone.
Hydroxychloroquine
The metabolism of Propafenone can be decreased when combined with Hydroxychloroquine.
Hydroxyzine
Hydroxyzine may increase the QTc-prolonging activities of Propafenone.
Hypoxis hemerocallidea root extract
The serum concentration of Propafenone can be decreased when it is combined with St. John's Wort.
Ibandronate
Ibandronate may increase the QTc-prolonging activities of Propafenone.
Ibandronic Acid
Ibandronate may increase the QTc-prolonging activities of Propafenone.
Ibuprofen
Ibuprofen may decrease the antihypertensive activities of Propafenone.
Ibutilide
Propafenone may increase the arrhythmogenic activities of Ibutilide.
Icatibant
Icatibant may decrease the antihypertensive activities of Propafenone.
Idelalisib
The serum concentration of Propafenone can be increased when it is combined with Idelalisib.
Iloperidone
Propafenone may increase the QTc-prolonging activities of Iloperidone.
Imatinib
The serum concentration of Propafenone can be increased when it is combined with Imatinib.
Imipramine
The serum concentration of Imipramine can be increased when it is combined with Propafenone.
Indacaterol
Indacaterol may increase the QTc-prolonging activities of Propafenone.
Indapamide
Indapamide may increase the QTc-prolonging activities of Propafenone.
Indinavir
The serum concentration of Indinavir can be increased when it is combined with Propafenone.
INDINAVIR ANHYDROUS
The serum concentration of Indinavir can be increased when it is combined with Propafenone.
Indobufen
Indobufen may decrease the antihypertensive activities of Propafenone.
Indomethacin
Indomethacin may decrease the antihypertensive activities of Propafenone.
Indoramin
Propafenone may increase the orthostatic hypotensive activities of Indoramin.
insulin human, rDNA origin
Propafenone may increase the hypoglycemic activities of Insulin Human.
Insulin, Pork
Propafenone may increase the hypoglycemic activities of Insulin Pork.
Insulin, Regular, Pork
Propafenone may increase the hypoglycemic activities of Insulin Pork.
Isavuconazole
The serum concentration of Propafenone can be increased when it is combined with Isavuconazole.
Isavuconazonium
The serum concentration of Propafenone can be increased when it is combined with Isavuconazonium.
Isoflurane
Isoflurane may increase the QTc-prolonging activities of Propafenone.
Isoflurophate
Isoflurophate may increase the bradycardic activities of Propafenone.
Isoniazid
The serum concentration of Isoniazid can be increased when it is combined with Propafenone.
Isradipine
The serum concentration of Propafenone can be increased when it is combined with Isradipine.
Itraconazole
The serum concentration of Propafenone can be increased when it is combined with Itraconazole.
Ivabradine
Ivabradine may increase the QTc-prolonging activities of Propafenone.
Ivacaftor
The serum concentration of Propafenone can be increased when it is combined with Ivacaftor.
Kebuzone
Kebuzone may decrease the antihypertensive activities of Propafenone.
Ketoconazole
The serum concentration of Ketoconazole can be increased when it is combined with Propafenone.
Ketoprofen
Ketoprofen may decrease the antihypertensive activities of Propafenone.
Ketorolac
Ketorolac may decrease the antihypertensive activities of Propafenone.
Labetalol
The serum concentration of Labetalol can be increased when it is combined with Propafenone.
Lacosamide
Propafenone may increase the atrioventricular blocking (AV block) activities of Lacosamide.
Lanreotide
Propafenone may increase the bradycardic activities of Lanreotide.
Lapatinib
Lapatinib may increase the QTc-prolonging activities of Propafenone.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Propafenone.
Leflunomide
Leflunomide may decrease the antihypertensive activities of Propafenone.
Lenvatinib
Propafenone may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Propafenone may increase the QTc-prolonging activities of Lenvatinib.
Leuprolide
Leuprolide may increase the QTc-prolonging activities of Propafenone.
Levobetaxolol
The serum concentration of Levobetaxolol can be increased when it is combined with Propafenone.
Levobunolol
The serum concentration of Levobunolol can be increased when it is combined with Propafenone.
Levofloxacin
Levofloxacin may increase the QTc-prolonging activities of Propafenone.
Levofloxacin Anhydrous
Levofloxacin may increase the QTc-prolonging activities of Propafenone.
Levomilnacipran
The serum concentration of Propafenone can be increased when it is combined with Levomilnacipran.
Levonordefrin
Levonordefrin may increase the atrioventricular blocking (AV block) activities of Propafenone.
Lidocaine
The serum concentration of Lidocaine can be increased when it is combined with Propafenone.
Limonene, (+)-
(4R)-limonene may decrease the antihypertensive activities of Propafenone.
Lisdexamfetamine
Propafenone may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Propafenone may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lithium
Lithium may increase the QTc-prolonging activities of Propafenone.
Lithium Cation
Lithium may increase the QTc-prolonging activities of Propafenone.
Lobeline
The risk or severity of adverse effects can be increased when Propafenone is combined with Lobeline.
Lofexidine
Lofexidine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Lopinavir
The serum concentration of Propafenone can be increased when it is combined with Lopinavir.
Lorcaserin
The serum concentration of Lorcaserin can be increased when it is combined with Propafenone.
Lornoxicam
Lornoxicam may decrease the antihypertensive activities of Propafenone.
Lovastatin
The serum concentration of Propafenone can be increased when it is combined with Lovastatin.
Loxoprofen
Loxoprofen may decrease the antihypertensive activities of Propafenone.
Lucinactant
Propafenone may increase the bradycardic activities of Lucinactant.
Luliconazole
The serum concentration of Propafenone can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Propafenone can be decreased when it is combined with Lumacaftor.
Lumefantrine
The serum concentration of Lumefantrine can be increased when it is combined with Propafenone.
Magnesium Salicylate
Magnesium salicylate may decrease the antihypertensive activities of Propafenone.
Malathion
Malathion may increase the bradycardic activities of Propafenone.
Manidipine
The serum concentration of Manidipine can be increased when it is combined with Propafenone.
Maprotiline
Maprotiline may increase the QTc-prolonging activities of Propafenone.
Masoprocol
Masoprocol may decrease the antihypertensive activities of Propafenone.
Meclofenamate
Meclofenamic acid may decrease the antihypertensive activities of Propafenone.
Meclofenamic Acid
Meclofenamic acid may decrease the antihypertensive activities of Propafenone.
Mefenamic Acid
Mefenamic acid may decrease the antihypertensive activities of Propafenone.
Mefloquine
Mefloquine may increase the QTc-prolonging activities of Propafenone.
Meloxicam
Meloxicam may decrease the antihypertensive activities of Propafenone.
Memantine
Memantine may increase the bradycardic activities of Propafenone.
Mephobarbital
The serum concentration of Propafenone can be decreased when it is combined with Methylphenobarbital.
Mepindolol
The serum concentration of Mepindolol can be increased when it is combined with Propafenone.
Mepivacaine
The serum concentration of Mepivacaine can be increased when it is combined with Propafenone.
Mesalamine
Mesalazine may decrease the antihypertensive activities of Propafenone.
Mesoridazine
Mesoridazine may increase the hypotensive activities of Propafenone.
Methacholine
Propafenone may increase the bronchoconstrictory activities of Methacholine.
Methadone
The serum concentration of Methadone can be increased when it is combined with Propafenone.
Methamphetamine
Methamphetamine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Methohexital
The serum concentration of Propafenone can be decreased when it is combined with Methohexital.
Methotrimeprazine
The serum concentration of Propafenone can be increased when it is combined with Methotrimeprazine.
Methyldopa
Methyldopa may increase the atrioventricular blocking (AV block) activities of Propafenone.
METHYLDOPA ANHYDROUS
Methyldopa may increase the atrioventricular blocking (AV block) activities of Propafenone.
Methylene blue
Methylene blue may increase the hypotensive activities of Propafenone.
METHYLEPHEDRINE, DL-
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Methylergonovine
Propafenone may increase the vasoconstricting activities of Methylergometrine.
Metipranolol
The serum concentration of Metipranolol can be increased when it is combined with Propafenone.
Metoclopramide
Metoclopramide may increase the QTc-prolonging activities of Propafenone.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Propafenone.
Metronidazole
Metronidazole may increase the QTc-prolonging activities of Propafenone.
Mexiletine
The metabolism of Propafenone can be decreased when combined with Mexiletine.
Midodrine
Propafenone may increase the bradycardic activities of Midodrine.
Midostaurin
The serum concentration of Propafenone can be increased when it is combined with Midostaurin.
Mifepristone
Mifepristone may increase the QTc-prolonging activities of Propafenone.
Milnacipran
The serum concentration of Propafenone can be increased when it is combined with Milnacipran.
Minaprine
Minaprine may increase the bradycardic activities of Propafenone.
Mirabegron
The serum concentration of Propafenone can be increased when it is combined with Mirabegron.
Mirtazapine
Mirtazapine may increase the QTc-prolonging activities of Propafenone.
Mitotane
The serum concentration of Propafenone can be decreased when it is combined with Mitotane.
Moexipril
Moexipril may increase the QTc-prolonging activities of Propafenone.
Moricizine
Moricizine may increase the hypotensive activities of Propafenone.
Moxifloxacin
Moxifloxacin may increase the QTc-prolonging activities of Propafenone.
Moxonidine
Moxonidine may increase the atrioventricular blocking (AV block) activities of Propafenone.
MYCOPHENOLATE
Mycophenolic acid may decrease the antihypertensive activities of Propafenone.
Mycophenolate Mofetil
Mycophenolate mofetil may decrease the antihypertensive activities of Propafenone.
Mycophenolic Acid
Mycophenolic acid may decrease the antihypertensive activities of Propafenone.
N-methylephedrine
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Nabumetone
Nabumetone may decrease the antihypertensive activities of Propafenone.
Nadolol
The serum concentration of Nadolol can be increased when it is combined with Propafenone.
Naftifine
Naftifine may decrease the antihypertensive activities of Propafenone.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Propafenone.
Naphazoline
Naphazoline may increase the atrioventricular blocking (AV block) activities of Propafenone.
Naproxen
Naproxen may decrease the antihypertensive activities of Propafenone.
Nebivolol
The serum concentration of Nebivolol can be increased when it is combined with Propafenone.
Nefazodone
The serum concentration of Propafenone can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Propafenone can be increased when it is combined with Nelfinavir.
Neostigmine
Neostigmine may increase the bradycardic activities of Propafenone.
Nepafenac
Nepafenac may decrease the antihypertensive activities of Propafenone.
Netupitant
The serum concentration of Propafenone can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Nevirapine can be increased when it is combined with Propafenone.
Nicardipine
The serum concentration of Nicardipine can be increased when it is combined with Propafenone.
Nicergoline
Propafenone may increase the orthostatic hypotensive activities of Nicergoline.
Nicotine
The risk or severity of adverse effects can be increased when Propafenone is combined with Nicotine.
Nicotine Polacrilex
The risk or severity of adverse effects can be increased when Propafenone is combined with Nicotine.
Nifedipine
The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Propafenone.
Niflumic Acid
Niflumic Acid may decrease the antihypertensive activities of Propafenone.
Nilotinib
The serum concentration of Nilotinib can be increased when it is combined with Propafenone.
Nimesulide
Nimesulide may decrease the antihypertensive activities of Propafenone.
Norepinephrine
Norepinephrine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Norfloxacin
Norfloxacin may increase the QTc-prolonging activities of Propafenone.
Nortriptyline
Propafenone may increase the orthostatic hypotensive activities of Nortriptyline.
O-PHENANTHROLINE
1,10-Phenanthroline may increase the bradycardic activities of Propafenone.
Octreotide
Octreotide may increase the QTc-prolonging activities of Propafenone.
Oenothera biennis seed extract
Evening primrose oil may decrease the antihypertensive activities of Propafenone.
Ofloxacin
Ofloxacin may increase the QTc-prolonging activities of Propafenone.
Olanzapine
Propafenone may increase the orthostatic hypotensive activities of Olanzapine.
Olaparib
The serum concentration of Propafenone can be increased when it is combined with Olaparib.
Olodaterol
Olodaterol may increase the QTc-prolonging activities of Propafenone.
Olopatadine
Olopatadine may decrease the antihypertensive activities of Propafenone.
Olsalazine
Olsalazine may decrease the antihypertensive activities of Propafenone.
Ondansetron
Ondansetron may increase the QTc-prolonging activities of Propafenone.
Orlistat
The serum concentration of Propafenone can be decreased when it is combined with Orlistat.
Osimertinib
The serum concentration of Propafenone can be increased when it is combined with Osimertinib.
Ouabain
The serum concentration of Ouabain can be increased when it is combined with Propafenone.
Ovine Digoxin Immune Fab
The serum concentration of Digoxin Immune Fab (Ovine) can be increased when it is combined with Propafenone.
Oxaprozin
Oxaprozin may decrease the antihypertensive activities of Propafenone.
Oxprenolol
The serum concentration of Oxprenolol can be increased when it is combined with Propafenone.
Oxymetazoline
Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Propafenone.
Oxyphenbutazone
Oxyphenbutazone may decrease the antihypertensive activities of Propafenone.
Oxytocin
Oxytocin may increase the QTc-prolonging activities of Propafenone.
Palbociclib
The serum concentration of Propafenone can be increased when it is combined with Palbociclib.
Paliperidone
Propafenone may increase the QTc-prolonging activities of Paliperidone.
Palmidrol
Palmidrol may decrease the antihypertensive activities of Propafenone.
Panobinostat
The serum concentration of Propafenone can be increased when it is combined with Panobinostat.
Parecoxib
Parecoxib may decrease the antihypertensive activities of Propafenone.
Paroxetine
The serum concentration of Propafenone can be increased when it is combined with Paroxetine.
Parthenolide
Parthenolide may decrease the antihypertensive activities of Propafenone.
Pasireotide
Pasireotide may increase the QTc-prolonging activities of Propafenone.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Propafenone.
Peginterferon Alfa-2b
The serum concentration of Propafenone can be decreased when it is combined with Peginterferon alfa-2b.
Penbutolol
The serum concentration of Penbutolol can be increased when it is combined with Propafenone.
Pentamidine
Pentamidine may increase the QTc-prolonging activities of Propafenone.
Pentobarbital
The serum concentration of Propafenone can be decreased when it is combined with Pentobarbital.
Perazine
Perazine may increase the hypotensive activities of Propafenone.
Perflutren
Perflutren may increase the QTc-prolonging activities of Propafenone.
Pergolide
Pergolide may increase the atrioventricular blocking (AV block) activities of Propafenone.
Periciazine
Propafenone may increase the orthostatic hypotensive activities of Propericiazine.
Perphenazine
Perphenazine may increase the hypotensive activities of Propafenone.
Phenindione
The serum concentration of Phenindione can be increased when it is combined with Propafenone.
Phenobarbital
The serum concentration of Propafenone can be decreased when it is combined with Phenobarbital.
Phenoxybenzamine
Propafenone may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Phenprocoumon
The serum concentration of Phenprocoumon can be increased when it is combined with Propafenone.
Phentolamine
Propafenone may increase the orthostatic hypotensive activities of Phentolamine.
Phentolamine Mesylate
Propafenone may increase the orthostatic hypotensive activities of Phentolamine.
Phenylbutazone
Phenylbutazone may decrease the antihypertensive activities of Propafenone.
Phenytoin
The serum concentration of Propafenone can be decreased when it is combined with Phenytoin.
Physostigmine
Physostigmine may increase the bradycardic activities of Propafenone.
Pilocarpine
The risk or severity of adverse effects can be increased when Propafenone is combined with Pilocarpine.
Pimecrolimus
Pimecrolimus may decrease the antihypertensive activities of Propafenone.
Pimozide
Propafenone may increase the QTc-prolonging activities of Pimozide.
Pindolol
The serum concentration of Pindolol can be increased when it is combined with Propafenone.
Pirfenidone
Pirfenidone may decrease the antihypertensive activities of Propafenone.
Piroxicam
Piroxicam may decrease the antihypertensive activities of Propafenone.
Piroxicam-Beta-Cyclodextrin
Piroxicam may decrease the antihypertensive activities of Propafenone.
Pizotyline
Propafenone may increase the orthostatic hypotensive activities of Pizotifen.
Poractant alfa
Propafenone may increase the bradycardic activities of Poractant alfa.
Posaconazole
The serum concentration of Propafenone can be increased when it is combined with Posaconazole.
Practolol
The serum concentration of Practolol can be increased when it is combined with Propafenone.
Prazosin
Propafenone may increase the orthostatic hypotensive activities of Prazosin.
Primaquine
Primaquine may increase the QTc-prolonging activities of Propafenone.
Primidone
The serum concentration of Propafenone can be decreased when it is combined with Primidone.
Procainamide
Propafenone may increase the QTc-prolonging activities of Procainamide.
Prochlorperazine
Prochlorperazine may increase the hypotensive activities of Propafenone.
Promazine
The serum concentration of Promazine can be increased when it is combined with Propafenone.
Promethazine
Promethazine may increase the QTc-prolonging activities of Propafenone.
Propiomazine
Propafenone may increase the orthostatic hypotensive activities of Propiomazine.
Propiverine
Propafenone may increase the orthostatic hypotensive activities of Propiverine.
Propofol
Propofol may increase the QTc-prolonging activities of Propafenone.
Propranolol
The serum concentration of Propranolol can be increased when it is combined with Propafenone.
Proscillaridin
The serum concentration of Proscillaridin can be increased when it is combined with Propafenone.
Protriptyline
Protriptyline may increase the QTc-prolonging activities of Propafenone.
Pseudoephedrine
Pseudoephedrine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Pyridostigmine
Pyridostigmine may increase the bradycardic activities of Propafenone.
Pyridostigmine Bromide
Pyridostigmine may increase the bradycardic activities of Propafenone.
Quetiapine
Propafenone may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Propafenone may increase the QTc-prolonging activities of Quetiapine.
Quinidine
Propafenone may increase the arrhythmogenic activities of Quinidine.
Quinine
The serum concentration of Quinine can be increased when it is combined with Propafenone.
Racepinephrine
Racepinephrine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Propafenone.
Regorafenib
Regorafenib may increase the bradycardic activities of Propafenone.
Regular Insulin, Human
Propafenone may increase the hypoglycemic activities of Insulin Human.
Remifentanil
Remifentanil may increase the bradycardic activities of Propafenone.
Reserpine
Reserpine may increase the hypotensive activities of Propafenone.
Resveratrol
Resveratrol may decrease the antihypertensive activities of Propafenone.
Rifabutin
The serum concentration of Propafenone can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Propafenone can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Propafenone can be decreased when it is combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Propafenone.
Rilpivirine
Rilpivirine may increase the QTc-prolonging activities of Propafenone.
Risperidone
Risperidone may increase the atrioventricular blocking (AV block) activities of Propafenone.
Ritonavir
The serum concentration of Propafenone can be increased when it is combined with Ritonavir.
Rivastigmine
Propafenone may increase the bradycardic activities of Rivastigmine.
Rofecoxib
Rofecoxib may decrease the antihypertensive activities of Propafenone.
Rolapitant
The serum concentration of Rolapitant can be increased when it is combined with Propafenone.
Ropinirole
The serum concentration of Ropinirole can be increased when it is combined with Propafenone.
Rucaparib
The serum concentration of Rucaparib can be increased when it is combined with Propafenone.
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Propafenone.
Salicylamide
Salicylamide may decrease the antihypertensive activities of Propafenone.
Salicylic Acid
Salicylic acid may decrease the antihypertensive activities of Propafenone.
Salmeterol
Salmeterol may increase the QTc-prolonging activities of Propafenone.
Salsalate
Salsalate may decrease the antihypertensive activities of Propafenone.
Saquinavir
Saquinavir may increase the arrhythmogenic activities of Propafenone.
Saquinavir Mesylate
Saquinavir may increase the arrhythmogenic activities of Propafenone.
Sarilumab
The therapeutic efficacy of Propafenone can be decreased when used in combination with Sarilumab.
Secobarbital
The serum concentration of Propafenone can be decreased when it is combined with Secobarbital.
Serratiopeptidase
Serrapeptase may decrease the antihypertensive activities of Propafenone.
Sertraline
Sertraline may increase the QTc-prolonging activities of Propafenone.
Sevoflurane
Sevoflurane may increase the QTc-prolonging activities of Propafenone.
Sildenafil
The serum concentration of Propafenone can be increased when it is combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Propafenone.
Siltuximab
The serum concentration of Propafenone can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Propafenone can be increased when it is combined with Simeprevir.
Solifenacin
Solifenacin may increase the QTc-prolonging activities of Propafenone.
Sorafenib
Sorafenib may increase the QTc-prolonging activities of Propafenone.
Sotalol
The serum concentration of Sotalol can be increased when it is combined with Propafenone.
ST. JOHN'S WORT EXTRACT
The serum concentration of Propafenone can be decreased when it is combined with St. John's Wort.
Sufentanil
Sufentanil may increase the bradycardic activities of Propafenone.
Sulfamethoxazole
Sulfamethoxazole may increase the QTc-prolonging activities of Propafenone.
Sulfasalazine
Sulfasalazine may decrease the antihypertensive activities of Propafenone.
Sulfisoxazole
The serum concentration of Propafenone can be increased when it is combined with Sulfisoxazole.
Sulindac
Sulindac may decrease the antihypertensive activities of Propafenone.
Sunitinib
Sunitinib may increase the QTc-prolonging activities of Propafenone.
Suprofen
Suprofen may decrease the antihypertensive activities of Propafenone.
Tacrine
Tacrine may increase the bradycardic activities of Propafenone.
Talinolol
The serum concentration of Talinolol can be increased when it is combined with Propafenone.
Tamoxifen
Tamoxifen may increase the QTc-prolonging activities of Propafenone.
Tamsulosin
Propafenone may increase the orthostatic hypotensive activities of Tamsulosin.
Telaprevir
The risk or severity of adverse effects can be increased when Telaprevir is combined with Propafenone.
Telavancin
Propafenone may increase the QTc-prolonging activities of Telavancin.
Telithromycin
The serum concentration of Propafenone can be increased when it is combined with Telithromycin.
Tenofovir Disoproxil
The metabolism of Propafenone can be decreased when combined with Tenofovir disoproxil.
Tenoxicam
Tenoxicam may decrease the antihypertensive activities of Propafenone.
Terazosin
Propafenone may increase the orthostatic hypotensive activities of Terazosin.
Terbinafine
The serum concentration of Propafenone can be increased when it is combined with Terbinafine.
Terbutaline
The serum concentration of Terbutaline can be increased when it is combined with Propafenone.
Terbutaline Sulfate
The serum concentration of Terbutaline can be increased when it is combined with Propafenone.
Teriflunomide
The serum concentration of Propafenone can be decreased when it is combined with Teriflunomide.
Tertatolol
The serum concentration of Tertatolol can be increased when it is combined with Propafenone.
Tetrabenazine
Propafenone may increase the QTc-prolonging activities of Tetrabenazine.
Theophylline
The serum concentration of Theophylline can be increased when it is combined with Propafenone.
Theophylline anhydrous
The serum concentration of Theophylline can be increased when it is combined with Propafenone.
Thiamylal
The serum concentration of Propafenone can be decreased when it is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Propafenone.
Thiopental
The serum concentration of Propafenone can be decreased when it is combined with Thiopental.
Thiopental Sodium
The serum concentration of Propafenone can be decreased when it is combined with Thiopental.
Thioproperazine
Propafenone may increase the orthostatic hypotensive activities of Thioproperazine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Propafenone.
Thiothixene
Thiothixene may increase the QTc-prolonging activities of Propafenone.
Tiaprofenic Acid
Tiaprofenic acid may decrease the antihypertensive activities of Propafenone.
Ticlopidine
The serum concentration of Ticlopidine can be increased when it is combined with Propafenone.
Timolol
The serum concentration of Timolol can be increased when it is combined with Propafenone.
Timolol Anhydrous
The serum concentration of Timolol can be increased when it is combined with Propafenone.
Tipranavir
The serum concentration of Propafenone can be increased when it is combined with Tipranavir.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Propafenone.
Tocilizumab
The serum concentration of Propafenone can be decreased when it is combined with Tocilizumab.
Tofacitinib
Tofacitinib may increase the bradycardic activities of Propafenone.
Tolazamide
Propafenone may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Propafenone may increase the orthostatic hypotensive activities of Tolazoline.
Tolbutamide
Propafenone may increase the hypoglycemic activities of Tolbutamide.
Tolfenamic Acid
Tolfenamic Acid may decrease the antihypertensive activities of Propafenone.
Tolmetin
Tolmetin may decrease the antihypertensive activities of Propafenone.
Tolterodine
Tolterodine may increase the QTc-prolonging activities of Propafenone.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Propafenone.
Toremifene
Propafenone may increase the QTc-prolonging activities of Toremifene.
Tranilast
Tranilast may decrease the antihypertensive activities of Propafenone.
Tranylcypromine
The serum concentration of Tranylcypromine can be increased when it is combined with Propafenone.
Trazodone
Propafenone may increase the orthostatic hypotensive activities of Trazodone.
Treprostinil
Treprostinil may increase the QTc-prolonging activities of Propafenone.
Tribenoside
Tribenoside may decrease the antihypertensive activities of Propafenone.
Trifluoperazine
Propafenone may increase the orthostatic hypotensive activities of Trifluoperazine.
Triflupromazine
Triflupromazine may increase the hypotensive activities of Propafenone.
Trimeprazine
Alimemazine may increase the hypotensive activities of Propafenone.
Trimethoprim
Trimethoprim may increase the QTc-prolonging activities of Propafenone.
Trimipramine
Propafenone may increase the orthostatic hypotensive activities of Trimipramine.
Triptorelin
Triptorelin may increase the QTc-prolonging activities of Propafenone.
Tubocurarine
Tubocurarine may increase the bradycardic activities of Propafenone.
Tyrothricin
Tyrothricin may increase the bradycardic activities of Propafenone.
Urapidil
Propafenone may increase the orthostatic hypotensive activities of Urapidil.
Valdecoxib
Valdecoxib may decrease the antihypertensive activities of Propafenone.
Vandetanib
Propafenone may increase the QTc-prolonging activities of Vandetanib.
Vardenafil
Vardenafil may increase the QTc-prolonging activities of Propafenone.
Varenicline
The risk or severity of adverse effects can be increased when Propafenone is combined with Varenicline.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Propafenone.
Venlafaxine
The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.
Verapamil
The serum concentration of Propafenone can be increased when it is combined with Verapamil.
Vilanterol
Vilanterol may increase the QTc-prolonging activities of Propafenone.
Vincristine
The excretion of Vincristine can be decreased when combined with Propafenone.
Voriconazole
The serum concentration of Propafenone can be increased when it is combined with Voriconazole.
Vorinostat
Vorinostat may increase the QTc-prolonging activities of Propafenone.
Warfarin
The serum concentration of Warfarin can be increased when it is combined with Propafenone.
Xylazine
Xylazine may increase the atrioventricular blocking (AV block) activities of Propafenone.
Xylometazoline
Xylometazoline may increase the atrioventricular blocking (AV block) activities of Propafenone.
Zileuton
Zileuton may decrease the antihypertensive activities of Propafenone.
Ziprasidone
The serum concentration of Ziprasidone can be increased when it is combined with Propafenone.
Zomepirac
Zomepirac may decrease the antihypertensive activities of Propafenone.
Zuclopenthixol
Propafenone may increase the QTc-prolonging activities of Zuclopenthixol.
